002720.KO · Kukje Pharma Co., Ltd

-

Please sign in to comment on 002720.KO

1 Comment

Admin

4 years, 1 month ago

Kukje Pharma Co., Ltd is currently in a long term downtrend where the price is trading 8.6% below its 200 day moving average.

From a valuation standpoint, the stock is 88.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.

Kukje Pharma Co., Ltd's total revenue sank by 3.9% to $28B since the same quarter in the previous year.

Its net income has dropped by 594.7% to $-4B since the same quarter in the previous year.

Finally, its free cash flow fell by 246.5% to $-5B since the same quarter in the previous year.

Based on the above factors, Kukje Pharma Co., Ltd gets an overall score of 1/5.

ISIN	KR7002720001
Sector	Healthcare
Exchange	KO
CurrencyCode	KRW
Industry	Drug Manufacturers - Specialty & Generic

Market Cap	94B
Beta	0.86
Dividend Yield	0.6%
PE Ratio	None
Target Price	None

ABOUT

Kukje Pharma Co., Ltd

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products. Kukje Pharma Co., Ltd. was founded in 1959 and is headquartered in Seongnam-si, South Korea.

002720.KO · Kukje Pharma Co., Ltd

-

Kukje Pharma Co., Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Kukje Pharma Co., Ltd using a moving average strategy